clinical trial · NCT07302698
PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption
Aspargo Labs, Inc·phase1·not yet recruiting·n = 24
Healthy VolunteersHezkue Oral Sildenafil Suspension
brief summary
This is an open-label, randomized study evaluating the pharmacokinetics and onset performance of Hezkue® oral sildenafil suspension administered following moderate alcohol consumption in healthy adult subjects. Participants will receive Hezkue® under controlled alcohol-exposure conditions. Pharmacokinetic sampling, onset assessments, and safety evaluations will be conducted throughout the study.
started
Mar 15, 2026
primary completion
May 15, 2026
completion
May 28, 2026
last updated
Dec 24, 2025
official title
Evaluation of the Pharmacokinetics and Onset Performance of Hezkue® Oral Sildenafil Suspension Following Alcohol Consumption in Healthy Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol